Matthew Nolan is a DPhil candidate in Clinical Neuroscience at the University of Oxford, supervised by Dr. Olaf Ansorge and Prof. Kevin Talbot. Matthew is working on selective vulnerability and somatic mosaicism in ALS/FTD, to understand why particular groups of neurons are more susceptible to disease pathology than others. Follow Matthew Nolan on Twitter @matthew__nolan
